Evidence map›Paper›PMID 30497693›Full record

ReviewTrends in pharmacological sciences2019

Non-genomic Effects of Glucocorticoids: An Updated View.

Reynold A Panettieri, Dedmer Schaafsma, Yassine Amrani, Cynthia Koziol-White, Rennolds Ostrom, Omar Tliba

Open access · greenAbstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed, 5 pooled it
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

154 citing papers in PubMed, 5 syntheses or guidelines pooled it, 267 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Non-Biologic Injections in Sports Medicine.Current reviews in musculoskeletal medicine · 2026
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 3 countries.

Reynold A PanettieriDepartment of Medicine, Rutgers Institute for Translational Medicine and Science, Robert Wood Johnson School of Medicine, New Brunswick, NJ, USA.
Dedmer SchaafsmaScience Impact, Winnipeg, Manitoba R3L 2S9, Canada.
Yassine AmraniDepartment of Infection, Immunity and Inflammation, Institute for Lung Health, Leicester Biomedical Research Center Respiratory, Leicester, UK.
Cynthia Koziol-WhiteDepartment of Medicine, Rutgers Institute for Translational Medicine and Science, Robert Wood Johnson School of Medicine, New Brunswick, NJ, USA.
Rennolds OstromDepartment of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA, USA.
Omar TlibaDepartment of Biomedical Sciences, College of Veterinary Medicine, Long Island University, Brookville, NY, USA. Electronic address: omar.tliba@liu.edu.
Chapman University · USImpact · CAJohnson University · USLong Island University · USNIHR Leicester Biomedical Research Centre · GBRutgers, The State University of New Jersey · US

Funding

Project 4 - OGR1- and TSPO- dependent mechanisms mediated by benzodiazepines affecting ASM contractionP01HL114471 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI LIGGETT, STEPHEN B · 2013 to 2023
$23.9M
Airway Inflammatory Pathways Regulating Glucocorticoid Receptor PhosphorylationR01HL111541 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI TLIBA, OMAR · 2012 to 2021
$3.3M
Molecular signal transduction of cAMP compartmentsR01GM107094 · NIGMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI OSTROM, RENNOLDS S · 2015 to 2022
$2.3M
NHLBI NIH HHS P01 HL114471NHLBI NIH HHS R01 HL111541NIGMS NIH HHS R01 GM107094
6 · The paper itself

Abstract

Glucocorticoid (GC) anti-inflammatory effects generally require a prolonged onset of action and involve genomic processes. Because of the rapidity of some of the GC effects, however, the concept that non-genomic actions may contribute to GC mechanisms of action has arisen. While the mechanisms have not been completely elucidated, the non-genomic effects may play a role in the management of inflammatory diseases. For instance, we recently reported that GCs 'rapidly' enhanced the effects of bronchodilators, agents used in the treatment of allergic asthma. In this review article, we discuss (i) the non-genomic effects of GCs on pathways relevant to the pathogenesis of inflammatory diseases and (ii) the putative role of the membrane GC receptor. Since GC side effects are often considered to be generated through its genomic actions, understanding GC non-genomic effects will help design GCs with a better therapeutic index.

Indexed as

AnimalsAnti-Inflammatory AgentsGenomicsGlucocorticoidsHumansInflammationReceptors, GlucocorticoidAnti-Inflammatory AgentsGlucocorticoidsReceptors, Glucocorticoidairway remodelingasthmacorticosteroidsglucocorticoid receptornon-genomicsmooth muscle

Identifiers

PMID30497693
PMCPMC7106476
OpenAlexW2902671349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.